When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 21 Apr 2025
Last updated: 27 Mar 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • underlying dermatosis
  • pruritus beginning during psychological stress
  • severe intractable itching
  • lichenification
  • erythematous to violaceous plaques
  • lesions on neck, ankles, scalp, vulva, scrotum, pubis, and extensor forearms

Other diagnostic factors

  • altered pigmentation
  • erosions
  • linear fissures
  • grouped hyperpigmented papules on the shins
  • hyperpigmented patch on the interscapular back
  • underlying psychiatric disorder
  • underlying systemic condition causing pruritus

Risk factors

  • atopic diathesis
  • environmental irritants
  • psychiatric disorder
  • dermatological disease
  • systemic conditions causing pruritus

Diagnostic investigations

Investigations to consider

  • skin biopsy
  • patch testing
  • potassium hydroxide preparation
  • fungal culture
  • skin scrapings
  • serum TSH and free T4
  • serum creatinine and urea and electrolytes
  • LFTs and gamma-GT
  • FBC

Treatment algorithm

Contributors

Authors

Brian L. Swick, MD
Brian L. Swick

Clinical Professor

University of Iowa Departments of Dermatology and Pathology

Iowa City Veterans Affairs Medical Center

Iowa City

IA

Disclosures

BLS declares that he has no competing interests.

Peer reviewers

Gil Yosipovitch, MD, FAAD

Professor

Stiefel Chair of Medical Dermatology

Director Miami Itch Center

Dr Phillip Frost Department of Dermatology and Cutaneous Surgery

Miller School of Medicine

University of Miami

Miami

FL

Disclosures

GY is an advisory board member for Abbvie, Arcutis, Escient Health, Eli Lilly, Galderma, LEO Pharma, Novartis, Pfizer, Pierre Fabre, Regeneron Pharmaceuticals, Inc., Sanofi, Vifor, GSK, and Kamari. He has received grants/research funding from Eli Lilly, LEO Pharma, Novartis, Pfizer, Galderma, Escient, Sanofi Regeneron, and Celldex. GY is an investigator for Regeneron Pharmaceuticals, Inc., and Sanofi.

Helen Goodyear, MBChB, MRCP, FRCPCH, MD, MMed

Consultant Paediatrician

Heartlands Hospital

Birmingham

UK

Disclosures

HG declares that she has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Lotti T, Buggaiani G, Prignano F. Prurigo nodularis and lichen simplex chronicus. Dermatol Ther. 2008;21:42-46.Full text  Abstract

Primary Care Dermatology Society. Lichen simplex (syn. circumscribed neurodermatitis). Jun 2022 [internet publication].Full text

van der Meijden WI, Boffa MJ, Ter Harmsel B, et al. 2021 European guideline for the management of vulval conditions. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):952-72.Full text  Abstract

American College of Obstetricians and Gynecologists. Practice bulletin no. 224: diagnosis and management of vulvar skin disorders. Jul 2020 [internet publication].Full text

Reference articles

A full list of sources referenced in this topic is available here.

Use of this content is subject to our disclaimer